These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21283829)

  • 1. Genomewide analyses define different modes of transcriptional regulation by peroxisome proliferator-activated receptor-β/δ (PPARβ/δ).
    Adhikary T; Kaddatz K; Finkernagel F; Schönbauer A; Meissner W; Scharfe M; Jarek M; Blöcker H; Müller-Brüsselbach S; Müller R
    PLoS One; 2011 Jan; 6(1):e16344. PubMed ID: 21283829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) cistrome reveals novel co-regulatory role of ATF4.
    Khozoie C; Borland MG; Zhu B; Baek S; John S; Hager GL; Shah YM; Gonzalez FJ; Peters JM
    BMC Genomics; 2012 Nov; 13():665. PubMed ID: 23176727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid.
    Rieck M; Meissner W; Ries S; Müller-Brüsselbach S; Müller R
    Mol Pharmacol; 2008 Nov; 74(5):1269-77. PubMed ID: 18701617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor beta/delta as a therapeutic target for metabolic diseases.
    Bedu E; Wahli W; Desvergne B
    Expert Opin Ther Targets; 2005 Aug; 9(4):861-73. PubMed ID: 16083348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARβ/δ in human cancer.
    Müller R
    Biochimie; 2017 May; 136():90-99. PubMed ID: 27916645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcriptional PPARβ/δ network in human macrophages defines a unique agonist-induced activation state.
    Adhikary T; Wortmann A; Schumann T; Finkernagel F; Lieber S; Roth K; Toth PM; Diederich WE; Nist A; Stiewe T; Kleinesudeik L; Reinartz S; Müller-Brüsselbach S; Müller R
    Nucleic Acids Res; 2015 May; 43(10):5033-51. PubMed ID: 25934804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reverse crosstalk of TGFβ and PPARβ/δ signaling identified by transcriptional profiling.
    Stockert J; Adhikary T; Kaddatz K; Finkernagel F; Meissner W; Müller-Brüsselbach S; Müller R
    Nucleic Acids Res; 2011 Jan; 39(1):119-31. PubMed ID: 20846954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Cytochrome P450 2B10 (CYP2B10) Expression in Liver by Peroxisome Proliferator-activated Receptor-β/δ Modulation of SP1 Promoter Occupancy.
    Koga T; Yao PL; Goudarzi M; Murray IA; Balandaram G; Gonzalez FJ; Perdew GH; Fornace AJ; Peters JM
    J Biol Chem; 2016 Nov; 291(48):25255-25263. PubMed ID: 27765815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three members of the human pyruvate dehydrogenase kinase gene family are direct targets of the peroxisome proliferator-activated receptor beta/delta.
    Degenhardt T; Saramäki A; Malinen M; Rieck M; Väisänen S; Huotari A; Herzig KH; Müller R; Carlberg C
    J Mol Biol; 2007 Sep; 372(2):341-55. PubMed ID: 17669420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-affinity peroxisome proliferator-activated receptor β/δ-specific ligands with pure antagonistic or inverse agonistic properties.
    Naruhn S; Toth PM; Adhikary T; Kaddatz K; Pape V; Dörr S; Klebe G; Müller-Brüsselbach S; Diederich WE; Müller R
    Mol Pharmacol; 2011 Nov; 80(5):828-38. PubMed ID: 21862691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-beta/delta antagonist GSK3787.
    Palkar PS; Borland MG; Naruhn S; Ferry CH; Lee C; Sk UH; Sharma AK; Amin S; Murray IA; Anderson CR; Perdew GH; Gonzalez FJ; Müller R; Peters JM
    Mol Pharmacol; 2010 Sep; 78(3):419-30. PubMed ID: 20516370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15-hydroxyeicosatetraenoic acid is a preferential peroxisome proliferator-activated receptor beta/delta agonist.
    Naruhn S; Meissner W; Adhikary T; Kaddatz K; Klein T; Watzer B; Müller-Brüsselbach S; Müller R
    Mol Pharmacol; 2010 Feb; 77(2):171-84. PubMed ID: 19903832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2.
    Rodríguez-Calvo R; Serrano L; Coll T; Moullan N; Sánchez RM; Merlos M; Palomer X; Laguna JC; Michalik L; Wahli W; Vázquez-Carrera M
    Diabetes; 2008 Aug; 57(8):2149-57. PubMed ID: 18443198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional profiling reveals divergent roles of PPARalpha and PPARbeta/delta in regulation of gene expression in mouse liver.
    Sanderson LM; Boekschoten MV; Desvergne B; Müller M; Kersten S
    Physiol Genomics; 2010 Mar; 41(1):42-52. PubMed ID: 20009009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons.
    Cimini A; Benedetti E; Cristiano L; Sebastiani P; D'Amico MA; D'Angelo B; Di Loreto S
    Neuroscience; 2005; 130(2):325-37. PubMed ID: 15664689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses.
    Aleshin S; Strokin M; Sergeeva M; Reiser G
    Neurochem Int; 2013 Oct; 63(4):322-30. PubMed ID: 23811400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function.
    Giordano Attianese GM; Desvergne B
    Nucl Recept Signal; 2015; 13():e001. PubMed ID: 25945080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels.
    Yessoufou A; Wahli W
    Swiss Med Wkly; 2010; 140():w13071. PubMed ID: 20842602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.
    Shan W; Palkar PS; Murray IA; McDevitt EI; Kennett MJ; Kang BH; Isom HC; Perdew GH; Gonzalez FJ; Peters JM
    Toxicol Sci; 2008 Oct; 105(2):418-28. PubMed ID: 18622026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) protects against ceramide-induced cellular toxicity in rat brain astrocytes and neurons by activation of ceramide kinase.
    Aleshin S; Reiser G
    Mol Cell Neurosci; 2014 Mar; 59():127-34. PubMed ID: 24513118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.